清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

S9 Adverse Events and Device Failures Associated With Pancreatic Stents: A Comprehensive Analysis Using the FDA's MAUDE Database

医学 不利影响 穿孔 胰腺炎 不良事件报告系统 数据库 食品药品监督管理局 内镜治疗 胰管 急诊医学 内科学 外科 内窥镜检查 医疗急救 材料科学 冶金 冲孔 计算机科学
作者
Fouad Jaber,Saqr Alsakarneh,Mohammad Jaber,Khalid K. Ahmed,Azizullah Beran,Khaled Elfert,Ahmed Salih,Manasik Abdu,Yazan Abboud,Zubair Khan,Mohamed Ismail,Joseph Sleiman,Mohamed Abdallah,Ala Abdel-Jalil,Mohammad Bilal
出处
期刊:The American Journal of Gastroenterology [Lippincott Williams & Wilkins]
卷期号:118 (10S): S8-S9
标识
DOI:10.14309/01.ajg.0000949676.28499.48
摘要

Introduction: Pancreatic duct stents (PDS) are widely used for the prevention of post-ERCP pancreatitis and for pancreatic endotherapy in chronic pancreatitis patients. Several commercially available PDS are commonly utilized. However, there is a paucity of data regarding the adverse events associated with PDS placement. This study aims to investigate the reported adverse events and device failures related to PDS, utilizing the Manufacturer and User Facility Device Experience (MAUDE) database maintained by the U.S. Food and Drug Administration (FDA). Methods: Post-marketing surveillance data from January 2010 to May 2023 were extracted from the FDA's MAUDE database to analyze the outcomes associated with PDS. Reports pertaining to the use of commonly used PDS including Advanix (Boston Scientfic), Geenan (Cook endoscopy), and Zimmon (Cook endoscopy) pancreatic stents were analyzed. The primary outcomes of interest were device problems and patient-related adverse events. Statistical analysis was performed using Microsoft Excel 2010, with calculation of pooled numbers and percentages for each device and patient adverse event. Results: During the study period, a total of 540 device problems and 582 patient-related adverse events were identified. Device failures (Figure 1) were primarily attributed to device or usage problems (n=145, 26.9%), followed by off-label use (n=144, 26.7%), and material or component issues (n=120, 22.2%). The most common patient-related adverse events were reported as having no harm or consequences to patients (n=400, 68.7%). Other reported patient adverse events included inflammation (n=24, 4.1%), perforation (n=16, 2.7%), foreign body presence (n=14, 2.4%), and pancreatitis (n=10, 1.7%). The highest number of device failures was associated with Zimmon pancreatic stents (n=217, 40.2%), followed by Geenen pancreatic stents (n=216, 40%) and Advanix (n=107, 19.8%). Device or usage problems were most frequently reported with the use of Zimmon stents (n=79, 36.4%), followed by Geenen stents (n=60, 27.8%). Conclusion: Most reported device-related issues were attributed to device or usage problems, and the majority of device failures did not result in harm to patients. Information from this study can be used in improving pancreatic duct stent designs for future iterations.Figure 1.: A) Device Failures associated with pancreatic stents. B) Patient-related adverse Events associated with pancreatic stents. Device or Use Problems (Adverse Event Without Identified Device or Use Problem, no apparent adverse events, Use of Device Problem, Improper or Incorrect Procedure or Method, Device Operates Differently Than Expected), Activation, Positioning or Separation Problem (Activation Failure, Activation, Difficult or Delayed Positioning, Positioning or Separation Problem, Positioning Failure, Positioning Problem), Material or Component Problems (Break, Material Deformation, Material Integrity Problem, Material Puncture/Hole, defective device, component failing, fracture), Device Markings or Packaging Problems (Device Markings/Labelling Problem, Device Packaging), Difficulties with Device (Difficult to Advance, Difficult to Remove, Device Difficult to Setup or Prepare, failure to advance), Migration (Migration or Expulsion of Device, Migration, Detachment of Device or Device Component), Sterilization (Problem with sterilization, Contamination /Decontamination Problem), Others (Entrapment of Device, Retraction Problem; Stretched, off label use, biocompatibility, fluid/blood leakage, appropriate code not available, insufficient information, obstruction of flow, leak/splash) Pain related (Abdominal pain/pain/implant pain), Bleeding-related (Bleeding/hemorrhage, blood).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科目三的应助被科研通管家采纳,获得10
20秒前
36秒前
帅气的依波完成签到,获得积分10
38秒前
轩辕中蓝完成签到 ,获得积分10
43秒前
刻苦的刚完成签到,获得积分10
47秒前
1分钟前
动听问旋完成签到,获得积分10
1分钟前
阔达的沛岚完成签到,获得积分10
1分钟前
cat发布了新的文献求助30
1分钟前
迷人不可完成签到,获得积分10
1分钟前
JTSW完成签到 ,获得积分10
1分钟前
大熊完成签到 ,获得积分10
1分钟前
会发光的小叶子的应助被he410采纳,获得10
1分钟前
孤独晓绿完成签到,获得积分10
1分钟前
丘比特的应助被跳跃火车采纳,获得10
2分钟前
朴素的嚓茶完成签到,获得积分10
2分钟前
科目三的应助被cat采纳,获得30
2分钟前
null的应助被科研通管家采纳,获得10
2分钟前
思源的应助被科研通管家采纳,获得10
2分钟前
2分钟前
虚拟的不乐完成签到,获得积分10
2分钟前
2分钟前
qin完成签到 ,获得积分10
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
跳跃火车发布了新的文献求助10
2分钟前
直率的晓亦完成签到,获得积分10
2分钟前
含蓄的觅波完成签到,获得积分10
3分钟前
3分钟前
跳跃火车完成签到,获得积分10
3分钟前
彩色的可冥完成签到,获得积分10
3分钟前
自信的纸鹤完成签到,获得积分10
3分钟前
胡萝卜完成签到,获得积分10
4分钟前
柠檬水完成签到 ,获得积分10
4分钟前
852的应助被科研通管家采纳,获得10
4分钟前
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166364
求助须知:如何正确求助?哪些是违规求助? 9559484
关于积分的说明 21750435
捐赠科研通 7757155
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553488
邀请新用户注册赠送积分活动 2473812